MOTEVALLI, M. H.; TAHERI, S.; PEIRAVIAN, F.; YOUSEFI, N. Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review. International Pharmacy Acta, [S. l.], v. 2, n. 1, p. 2e10:1–6, 2019. DOI: 10.22037/ipa.v2i1.24856. Disponível em: https://journals.sbmu.ac.ir/acta/article/view/24856. Acesso em: 4 may. 2024.